Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
128.37 USD | -0.69% |
|
+1.45% | -20.96% |
07-17 | UBS Adjusts Clorox Price Target to $134 From $150, Maintains Neutral Rating | MT |
07-15 | Citigroup Adjusts Clorox Price Target to $135 From $140, Maintains Neutral Rating | MT |
Company Valuation: The Clorox Company
Data adjusted to current consolidation scope
Fiscal Period: June | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|---|---|---|---|
Capitalization 1 | 27,626 | 22,376 | 17,352 | 19,661 | 16,948 | 15,822 | - | - |
Change | - | -19% | -22.45% | 13.31% | -13.8% | -6.64% | - | - |
Enterprise Value (EV) 1 | 29,535 | 24,841 | 19,880 | 21,821 | 19,231 | 18,163 | 18,539 | 18,508 |
Change | - | -15.89% | -19.97% | 9.77% | -11.87% | -5.55% | 2.07% | -0.17% |
P/E ratio | 29.8x | 32.2x | 37.8x | 133x | 60.7x | 22x | 20x | 18.3x |
PBR | 28.2x | 53.9x | 31.2x | 89.5x | 51.7x | 80.7x | 56.1x | 34.3x |
PEG | - | -1.3x | -1.1x | -2x | 0.7x | 0x | 2.04x | 1.98x |
Capitalization / Revenue | 4.11x | 3.05x | 2.44x | 2.66x | 2.39x | 2.24x | 2.31x | 2.23x |
EV / Revenue | 4.39x | 3.38x | 2.8x | 2.95x | 2.71x | 2.58x | 2.71x | 2.6x |
EV / EBITDA | 20.3x | 16.9x | 20.4x | 18.9x | 15x | 12.8x | 13.6x | 12.6x |
EV / EBIT | 23.2x | 19.8x | 26.5x | 23.8x | 18.4x | 15.1x | 16.2x | 14.8x |
EV / FCF | 22.9x | 26.3x | 37.2x | 23.5x | 39.8x | 22.3x | 26.4x | 22.7x |
FCF Yield | 4.37% | 3.8% | 2.69% | 4.26% | 2.51% | 4.49% | 3.78% | 4.41% |
Dividend per Share 2 | 4.24 | 4.49 | 4.66 | 4.72 | 4.8 | 4.942 | 5.155 | 5.355 |
Rate of return | 1.93% | 2.5% | 3.31% | 2.97% | 3.52% | 3.85% | 4.02% | 4.17% |
EPS 2 | 7.36 | 5.58 | 3.73 | 1.2 | 2.25 | 5.838 | 6.409 | 7.001 |
Distribution rate | 57.6% | 80.5% | 125% | 393% | 213% | 84.7% | 80.4% | 76.5% |
Net sales 1 | 6,721 | 7,341 | 7,107 | 7,389 | 7,093 | 7,049 | 6,846 | 7,105 |
EBITDA 1 | 1,454 | 1,467 | 974 | 1,153 | 1,280 | 1,423 | 1,362 | 1,467 |
EBIT 1 | 1,274 | 1,256 | 750 | 917 | 1,045 | 1,200 | 1,141 | 1,248 |
Net income 1 | 939 | 710 | 462 | 149 | 280 | 732.4 | 802.2 | 884.2 |
Net Debt 1 | 1,909 | 2,465 | 2,528 | 2,160 | 2,283 | 2,341 | 2,717 | 2,686 |
Reference price 2 | 219.37 | 179.91 | 140.98 | 159.04 | 136.47 | 128.37 | 128.37 | 128.37 |
Nbr of stocks (in thousands) | 125,934 | 124,372 | 123,080 | 123,624 | 124,188 | 123,253 | - | - |
Announcement Date | 8/3/20 | 8/3/21 | 8/3/22 | 8/2/23 | 8/1/24 | - | - | - |
1USD in Million2USD
Estimates
P/E ratio, Detailed evolution
P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
---|---|---|---|---|---|---|
21.99x | 2.58x | 12.76x | 3.85% | 15.82B | ||
17.7x | 2.98x | 10.7x | 4.15% | 45.76B | ||
28.6x | 4.06x | 17.47x | 1.23% | 23.79B | ||
14.02x | 1.68x | 9.28x | 4.22% | 4.57B | ||
14.64x | 1.67x | 10.37x | 5.77% | 3.53B | ||
39.32x | 4.85x | 25.97x | - | 2.95B | ||
16.35x | 0.71x | 5.8x | 2.05% | 2.7B | ||
33.07x | 4.1x | 23.5x | 1.41% | 1.46B | ||
Average | 23.21x | 2.83x | 14.48x | 3.24% | 12.57B | |
Weighted average by Cap. | 21.50x | 3.08x | 13.05x | 3.35% |
Year-on-year evolution of the PER
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Equities
- CLX Stock
- Valuation The Clorox Company
Select your edition
All financial news and data tailored to specific country editions

MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition